Source: Virtual Congress 2020 – Neonatal and paediatric intensive care: diagnosis, management and outcomes
Disease area: Paediatric lung diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
H. Ambulkar (London, United Kingdom), E. Williams (London, United Kingdom), A. Hickey (London, United Kingdom), R. Bhat (London, United Kingdom), T. Dassios (London, United Kingdom), A. Greenough (London, United Kingdom). Feasibility of less invasive surfactant administration (LISA) in the delivery suite. 2821

Member's Comments

No comment yet.

Related content which might interest you: Retrospective review of patient logging system data from an adaptive aerosol delivery system used for the delivery of iloprost inhalation solution Source: Annual Congress 2008 - Pulmonary hypertension II Year: 2008 Development of in-vitro models for aerosolized surfactant therapy to support customization of a novel nebulizer system based on eflow technology Source: Annual Congress 2009 - Respiratory disorders of the newborn Year: 2009 Late Breaking Abstract - Less invasive surfactant administration (LISA) to preterm infants on high flow nasal cannula (nHFT). Source: Virtual Congress 2021 – Respiratory disorders in neonatal and paediatric intensive care Year: 2021 Effectiveness, safety and delivery of pulmonary rehabilitation Source: Virtual Congress 2021 – Living with a new norm: providing quality care in the post-COVID era Year: 2021 Macro and microscopic evaluation of paclitaxel delivery in the airway with a novel endobronchial injectable drug delivery catheter Source: Annual Congress 2013 –Therapeutical bronchoscopy for treatment of airway disorders: laser, stents and more Year: 2013 In vitro characterisation of a novel electronic nebulizer utilising a customised single dose bfs-vial to improve handling and delivery performance Source: Annual Congress 2009 - New aspects of inhalation therapy Year: 2009 Aerosol delivery Source: Annual Congress 2013 –PG4 How to build an experimental animal lung lab Year: 2013 Enhancing implementation, use, and delivery of pulmonary rehabilitation Source: Guideline 2015 Year: 2015 Assessment of two different methods of bronchodilators delivery during noninvasive ventilation. Experimental in vivo approach Source: Eur Respir J 2004; 24: Suppl. 48, 315s Year: 2004 Distribution of technetium-99m-labelled QVARTM delivered using an AutohalerTM device in children Source: Eur Respir J 2003; 21: 1007-1011 Year: 2003 Improvement of QVAR delivery through a better sorting of drug particles: development of an innovative and easy-to-use spacer Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020 Use of a telemedicine application to examine patient logging system data from a 3-month use of an adaptive aerosol delivery system by patients with COPD Source: Annual Congress 2008 - Integrated care and long-term strategies Year: 2008 Nebulised antibiotics with the I-neb adaptive aerosol delivery (AAD) system: Impact on adherence in cystic fibrosis (CF) patients Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems Year: 2012 Effect of different connections on aerosol delivery during non-invasive mechanical ventilation. Source: Virtual Congress 2020 – Non-invasive ventilation and nasal high flow: technical aspects and predictive scores Year: 2020 Comparison of aerosol delivery from two inhaler technique-guidance devices. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Bench performance and lung deposition of the I-neb adaptive aerosol delivery system Source: Annual Congress 2007 - New developments in thoracic imaging modalities and illustrated thorax pathologies Year: 2007 Incremental midazolam versus midazolame/rentanyl sedation during flexible bronchoscopy. Safety and tolerance in relation to the complexity of intervention Source: Annual Congress 2012 - The broad spectrum of diagnostic bronchoscopy Year: 2012 Effect of 3 different nebulisers on the aerosol delivery performance of isotonic disodium comoglycate (IsoCROM) Source: Eur Respir J 2006; 28: Suppl. 50, 212s Year: 2006 Expanding role of aerosols: systemic drug delivery, gene therapy and vaccination Source: Annual Congress 2007 - ISAM - Expanding role of aerosols: systemic drug delivery, gene therapy and vaccination Year: 2007 In vitro performance of the prodose AAD® handheld - a new portable aerosol delivery system Source: Eur Respir J 2004; 24: Suppl. 48, 581s Year: 2004